U.S. Making It Easier to Access COVID-19 Treatment Paxlovid
First test-to-treat site backed by the federal government is opening in Rhode Island
Monkeypox Poses Challenges, Even in High-Income Countries
Three of seven patients in U.K. were treated with brincidofovir; all developed elevated liver enzyme resulting in cessation of therapy
Survey IDs Challenges of Health Care Environmental Hygiene
50 of 51 health care facilities surveyed lacking in some or all of the five components of the WHO multimodal hand hygiene strategy
Post-COVID Conditions Are Common Among Adult Survivors
More than twofold risk of acute pulmonary embolism and respiratory signs and symptoms among survivors aged 18 to 64, ≥65 years
Burden of Persistent Symptoms High After COVID-19 Infection
No specific causes of symptoms of postacute sequelae of SARS-CoV-2 infection identified
H. pylori Infection Often Detected in Patients With Dyspepsia
Study in Ethiopia shows risk factors for peptic ulcer disease include H. pylori infection and NSAID/acetylsalicylic acid use
COVID-19 Can ‘Rebound’ After Treatment With Paxlovid, CDC Says
In these cases, the illness improved or resolved within an average of three days
Odds of COVID-19 Mortality Lower for Women Receiving HRT
Receiving hormone replacement therapy within six months of recorded COVID-19 diagnosis linked to reduction in mortality
Physicians Often Experience Mistreatment, Discrimination
Experience of mistreatment or discrimination by patients, families, visitors independently linked with higher odds of burnout
Antibody Levels After COVID-19 Vaccination Inversely Linked to Body Weight
Inverse correlation sustained for up to six months following two doses of BNT162b2 in small cohort of healthy young and middle-aged adults
